Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Viridian Therapeutics, Inc. | VRDN | 3.59M | $66M |
Solid Biosciences Inc. | SLDB | 3.57M | $35.61M |
Guardant Health, Inc. | GH | 3.39M | $509.1M |
LB Pharmaceuticals Inc Common Stock | LBRX | 3.35M | $108.82M |
BioMarin Pharmaceutical Inc. | BMRN | 3.31M | $189.25M |
Celldex Therapeutics, Inc. | CLDX | 2.94M | $109.37M |
Definium Therapeutics, Inc. | DFTX | 2.75M | $129.36M |
Corvus Pharmaceuticals, Inc. | CRVS | 2.49M | $37.23M |
Ionis Pharmaceuticals, Inc. | IONS | 2.2M | $174.44M |
Veradermics, Incorporated | MANE | 2M | $245.88M |
Cogent Biosciences, Inc. | COGT | 2M | $77.4M |
Kura Oncology, Inc. | KURA | 1.98M | $21.7M |
Oruka Therapeutics, Inc. | ORKA | 1.93M | $183.3M |
GRAIL Inc. | GRAL | 1.83M | $125.27M |
Olema Pharmaceuticals, Inc. | OLMA | 1.5M | $18.77M |
Dyne Therapeutics, Inc. | DYN | 1.5M | $33.31M |
Enanta Pharmaceuticals, Inc. | ENTA | 1.44M | $21.06M |
Beam Therapeutics Inc. | BEAM | 1M | $34.32M |
Harrow Health, Inc. | HROW | 969K | $41.15M |
Alnylam Pharmaceuticals, Inc. | ALNY | 825K | $248.35M |